References
- Bernkop-Schnürch A, Dünnhaupt S. Chitosan-based drug delivery systems. Eur J Pharm Biopharm 2012;81:463–9
- Maestrelli F, Cirri M, Mennini N, et al. Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery. Drug Dev Ind Pharm 2012;38:1142–51
- Lankalapalli S, Kolapalli RM. Biopharmaceutical evaluation of diclofenac sodium controlled release tablets prepared from gum karaya-chitosan polyelectrolyte complexes. Drug Dev Ind Pharm 2012;38:815–24
- Silva HSRC, Santos KSCR, Ferreira EI. Quitosana e derivados hidrossolúveis, aplicações farmacêuticas e avanços. Quim Nova 2006;29:776–85
- Chen X-G, Park H-J. Chemical characteristics of O-carboxymethylchitosans related to the preparation conditions. Carbohyd Polym 2003;53:355–9
- Martin P, Daga N, Zandonai CF, et al. Release of tetracycline from O-carboxymethylchitosan films. Pharm Dev Technol 2011;16:179–86
- Liu YF, Huang KL, Peng DM, et al. Preparation and characterization of glutaraldehyde cross-linked O-carboxymethylchitosan microsphere for controlled delivery of pazufloxacin mesilate. Int J Biol Macromol 2007;41:87–93
- Zhu A, Jin W, Yuan L, et al. O-carboxymethylchitosan-based novel gatifloxacin delivery system. Carbohyd Polym 2007;68:693–700
- Zhu AP, Liu JH, Ye WH. Effective loading and controlled release of camptothecin by O-carboxymethylchitosan aggregates. Carbohyd Polym 2006;63:89–96
- Chaibva FA, Khamanga SM, Walker RB. Swelling, erosion and drug release characteristics of salbutamol sulfate from hydroxypropyl methylcellulose-based matrix tablets. Drug Dev Ind Pharm 2010;36:1497–510
- Yadav K, Yadav D, Srivastava AK. Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of venlafaxine hydrochloride. Drug Dev Ind Pharm 2012 . [Epub ahead of print]. doi:10.3109/03639045.2012.704381
- Hiremath PS, Saha RN. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations. Int J Pharm 2008;362:118–25
- Lamoudi L, Chaumeil JC, Daoud K. Development of gastro intestinal sustained release tablet formulation containing acryl-EZE and pH-dependent swelling HPMC K 15 M. Drug Dev Ind Pharm 2012;38:515–20
- Ikeuchi-Takahashi Y, Watanabe N, Sasatsu M, Onishi H. Formulation and evaluation of matrix type mucoadhesive tablets aimed at treating oral aphtha. Drug Dev Ind Pharm 2012 . [Epub ahead of print]. doi:10.3109/03639045.2012.717297
- Gohel MC, Patel MM, Amin AF. Development of modified release diltiazem HCl tablets using composite index to identify optimal formulation. Drug Dev Ind Pharm 2003;29:565–74
- Liu XF, Guan YL, Zang DZ, et al. Antibacterial action of chitosan and carboxymethylchitosan. J Appl Polym Sci 2001;79:1324–35
- Casu B, Gennaro UA. A conductimetric method for the determination of sulphate and carboxyl groups in heparin and other mucopolysaccharides. Carbohyd Res 1975;39:168–76
- European Pharmacopeia. 6th ed. Strasbourg: Council of Europe, 2007
- United States Pharmacopeia. 29th ed. Rockville (MD): United States Pharmacopeial Convention; 2006
- Rojas J, Kumar V. Co-processing of cellulose II with amorphous silicon dioxide: effect of silicification on the powder and tableting properties. Drug Dev Ind Pharm 2012;38:209–26
- Brouillet F, Baylac G, Cartilier L, Bataille B. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug release: development of a spray-drying manufacturing process. Drug Dev Ind Pharm 2010;36:795–805
- Colombo P, Betini R, Santi P, Peppas NA. Swellable matrices for controlled drug delivery: gel-layer behavior, mechanisms and optimal performance. PSTT 2000;3:198–204
- Agnes EJ, González Ortega G. Modelos matemáticos e físico-química da difusão. Cad Farm 2003;19:9–19